Recently, pro-gastrin-releasing peptide (pro-GRP) became available as an alternative sensitive, specific and reliable tumor marker for patients with small cell lung cancer (SCLC), both in limited (LD) and diffuse disease (DD).

Clinical implications for pro-GRP in small cell lung cancer. A single center experience / S. Cavalieri, D. Morelli, A. Martinetti, G. Galli, F. Nichetti, F.G.M. DE BRAUD, M. Platania. - In: THE INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS. - ISSN 0393-6155. - 33:1(2018), pp. 55-61. [10.5301/ijbm.5000305]

Clinical implications for pro-GRP in small cell lung cancer. A single center experience

S. Cavalieri;G. Galli;F. Nichetti;F.G.M. DE BRAUD;
2018

Abstract

Recently, pro-gastrin-releasing peptide (pro-GRP) became available as an alternative sensitive, specific and reliable tumor marker for patients with small cell lung cancer (SCLC), both in limited (LD) and diffuse disease (DD).
Settore MED/06 - Oncologia Medica
25-set-2017
Article (author)
File in questo prodotto:
File Dimensione Formato  
ijbm.5000305.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 490.22 kB
Formato Adobe PDF
490.22 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/551868
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 11
social impact